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Pax6, a member of the paired-family of transcription factors, exhibits restricted expression and essential functions in the developing eye,
olfactory system, central nervous system, and pancreas. To understand Pax6 function, which critically depends on induction of proper expression
levels during development, it is necessary to elucidate the molecular mechanisms governing Pax6 transcription. Although previous studies using
classic transgenic approaches have provided a wealth of information about the distribution and types of regulatory elements involved in Pax6
regulation, genetic studies in both humans and mice indicate that these enhancers alone are not sufficient for fully regulated Pax6 expression. We
report here our analysis of mice transgenic for a 160 kb mouse Pax6 BAC transgene, which was generated as a necessary first step towards testing
the long-range control of Pax6 expression in vivo. We show that this BAC transgene replicates Pax6 expression in the eye. This is the first time
that a reporter transgene has been expressed in a normal Pax6-like pattern in all of the tissues of the eye and defines an eye regulatory region
within the Pax6 downstream regulatory region (DRR). Second, we show that this BAC transgene contains all of the cis regulatory elements
required for normal Pax6 expression within the developing embryo, except for within the diencephalon and olfactory bulb. Third, we show that
this transgene is subject to Pax6 autoregulation. Lastly, we identify, for the first time in mammals, an isoform of the Pax6 protein lacking the
paired domain. This isoform is expressed in the developing olfactory bulb and eye. Over-expression of Pax6ΔPD causes a microphthalmic
phenotype in both Pax6+/+ mice and Pax6+/− mice. These results demonstrate a role for Pax6ΔPD in eye development, which appears to be
different than that ascribed to either canonical Pax6 or Pax6(5a).
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The Pax6 transcription factor is highly conserved among
metazoans and controls key steps in eye development (see
review, Gehring, 2005). In the mammalian and avian eye, Pax6
is expressed in the developing optic vesicle, lens, cornea, iris,
and neural retina (Davis and Reed, 1996; Grindley et al., 1995;
Koroma et al., 1997; Martin et al., 1992; Walther and Gruss,
1991). These sites of expression correlate with Pax6 ocular
function. In mammals, Pax6 mutations are associated with
aniridia in humans (Glaser et al., 1992; Hanson et al., 1993; Ton
et al., 1991) and the Small eye (Sey) trait in rodents (Hill et al.,
1991; Matsuo et al., 1993). Aniridia and Sey are semidominant⁎ Corresponding author. Fax: +1 706 542 4271.
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doi:10.1016/j.ydbio.2005.12.041panocular disorders, resulting from heterozygosity of null
alleles, which include severe iris hypoplasia, defects in the
neural retina, and risk for acquired corneal opacification,
cataracts, and glaucoma. Although the mechanisms underlying
these haploinsufficient phenotypes are poorly understood, it is
clear that Pax6 has multiple functions in both the developing
and adult eye and affects cell fate, cell proliferation, and
patterning. Recent evidence suggests that these diverse func-
tions are mediated by different isoforms of the Pax6 protein
(Azuma et al., 1999, 2005; Haubst et al., 2004; Singh et al.,
2002).
Three isoforms of the Pax6 protein have been reported in
vertebrates. The canonical form of Pax6 contains two DNA-
binding domains, the paired domain (PD) and a paired-like
homeodomain (HD) linked by a glycine-rich region, and a
proline–serine–threonin (PST)-rich transactivation domain
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Walther and Gruss, 1991). This isoform is expressed in most
cells that express Pax6 (Anderson et al., 2002; Kammandel et
al., 1999; Plaza et al., 1999; Xu and Saunders, 1997; Xu et al.,
1999). The second Pax6 isoform, which is generated by
alternative splicing, contains an exon 5a-encoded 14 amino acid
insertion in the N-terminal subunit of the PD (Epstein et al.,
1994; Glaser et al., 1992; Walther and Gruss, 1991). This
isoform has been detected in the brain, spinal cord, olfactory
epithelium, and eye (Azuma et al., 2005; Epstein et al., 1994;
Pinson et al., 2005; Zhang et al., 2001). The third isoform,
which was identified in quail neuroretina extracts (Carriere et
al., 1993), lacks the paired domain (Pax6ΔPD). Transcripts
predicted to encode for this isoform have been identified in
mammals and can be generated from alternative internal
promoters (Kammandel et al., 1999; Kleinjan et al., 2004;
Mishra et al., 2002) or by alternative splicing (Gorlov and
Saunders, 2002; Mishra et al., 2002). Little is known about
where this isoform is expressed or its normal function in vivo.
Insights into different aspects of Pax6 function can be
facilitated by elucidation of the mechanisms governing Pax6
expression. Modular cis regulatory elements controlling
different aspects of Pax6 expression have been defined 5′,
internal, and 3′ to the Pax6 transcript unit using transgene
reporter assays (Griffin et al., 2002; Kammandel et al., 1999;
Kleinjan et al., 2001, 2004; Plaza et al., 1999; Williams et al.,
1998; Xu et al., 1999). While some of these elements are widely
spaced in the Pax6 locus, they exhibit overlapping tissue
specificity, particularly in the eye and diencephalon. Although
collectively these elements account for the majority of the Pax6
expression domain observed in developing mice, genetic
evidence from humans and mice suggests that these enhancers
are insufficient for normal Pax6 expression. Whereas aniridia is
typically caused by heterozygous null mutations within PAX6 or
cytogenetic deletions of chromosome 11p13 that encompass
PAX6, chromosomal rearrangements also have been described
that disrupt 11p13 but spare the PAX6 transcription unit (Fantes
et al., 1995; Fukushima et al., 1993; Kleinjan et al., 2001;
Lauderdale et al., 2000; Simola et al., 1983; Ton et al., 1991).
The breakpoints of these aniridia-associated rearrangements are
all located 3′ to PAX6, with the most distal, designated as
“SIMO,” located ∼124 kb 3′ the PAX6 polyadenylation sites
(Fantes et al., 1995; Kleinjan et al., 2001; Lauderdale et al.,
2000; Simola et al., 1983). These rearrangements presumably
cause a loss of gene expression by removing a distant positively
acting cis regulatory element required for PAX6 eye expression.
Consistent with this, in mice, human YAC transgenes spanning
PAX6 rescue the Sey phenotype and homozygous Sey lethality
when the YAC contained DNA 3′ to the SIMO breakpoint
(Kleinjan et al., 2001; Schedl et al., 1996). Similarly, we
showed, using human × mouse somatic cell hybrids that
chromosomal rearrangements 3′ to human PAX6 blocked gene
expression even though the transcript unit was intact and
included known eye elements (Lauderdale et al., 2000). These
results argue strongly that Pax6 eye expression requires
additional 3′ long-range enhancers located within a region
designated as the Pax6 downstream regulatory region (DRR),which extends over a ∼75 kb region 3′ to the SIMO breakpoint
(Kleinjan et al., 2001). Although cis regulatory elements have
been identified within the DRR (Kleinjan et al., 2001), their
mechanisms of action remain unknown.
We are studying the long-range regulatory mechanisms
governing Pax6 transcription in the mouse using bacterial
artificial chromosomes (BACs). Because Pax6 transcriptional
control is complex, the use of large genomic constructs will
avoid potential problems associated with “classical” reporter
transgene approaches, which are subject to position effects and
do not take into account the cooperative interactions between
regulatory elements that would normally exist within the
genome. We report here that mice containing a Pax6 BAC
transgene, which included the Pax6 transcript unit and a cluster
of evolutionarily conserved sequences located∼100 kb 3′ to the
Pax6 coding region, are sufficient to recapitulate the native
Pax6 expression pattern in all regions of the developing mouse,
except the diencephalon and olfactory bulb. Our data strongly
suggest the presence of additional Pax6 enhancers for the
diencephalon and olfactory bulb that reside outside the genomic
DNA contained in the Pax6 BAC transgene. Additionally, we
identify, for the first time in mammals, an isoform of the Pax6
protein lacking the paired domain, which is expressed in both
the developing eye and olfactory bulb and has a role in eye
development.
Methods
Comparative genomics
The genomic sequence data used to generate the scale drawings and also for
comparative genomics were obtained from the National Center for Biotechnol-
ogy Information (NCBI) or the Sanger Institute. Sequences with the following
GenBank accessions nos. were used in this study: human, Z95332, Z83307,
Z83001, Z83006, Z83009, Z83008, Z83308, AC131571, Z86001, AL136384;
mouse, AL512589, AL590380; chicken, AC14046, AC141860; zebrafish
AL929172.
Identification and molecular characterization of Pax6 BACs
BACs containing sequences homologous to the SIMO region were identified
by screening a mouse ES-129/SvJ BAC library (Release II; Genome Systems,
Inc) with a 32P-labeled single copy probe derived from the SIMO breakpoint
(Gessler et al., 1989). The four BACs that gave the strongest signal, 250b19,
293d08, 427g18, and 432m12, were then screened for Pax6 exon 0 using a 32P-
labeled mouse Pax6 exon 0 probe, derived from a cDNA clone, at high
stringency (65°C, 0.2× SSC final wash). This probe detected BACs 293d08 and
432m12. BAC ends were sequenced by automated DNA sequencing, and
sequence analysis was performed using MacVector (Accelrys, Inc) and BLAST
(NCBI). The internal structures of these two BACs were determined by
fingerprint analysis using, separately, BamHI and EcoRI. Southern analysis
using single copy 32P-labeled probes was used to directly compare BamHI
restriction fragments from BAC DNA to those obtained from genomic DNA
prepared from 129/SvJ mice.
BAC transgene construction
Pax6 BAC 293d08 was modified by targeted insertion of an EGFP
pA reporter cassette into Pax6 exon 4 using the prophage BAC
modification system (Lee et al., 2001; Yu et al., 2000). The EGFP-
FRT-kan-FRT targeting cassette was PCR-amplified from pCS2+MTeGFP-
FRT-kan-FRT using the Pax6 forward targeting primer, E4RECF, 5′-
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CAGCATGGTGAGCAAGGGCGAGGAG3′ and the Pax6 reverse targeting
primer, E4RECR, 5′-TAACCCACGGCCCGCACGCCTCCAGCCCAA-
CAGTCCAGAGAAAGACCTGAGTATTCCAGAAGTAGTGAG-3′. Nucleo-
tides in italics are homologous to Pax6 sequences and those in roman are
homologous to amplification cassette. The pCS2+MTeGFP-FRT-kan-FRT
plasmid (gift of X. Fan and S. Dougan, UGA) was constructed by inserting
the FRT-kan-FRT SacII fragment of pIGCN21 (gift of N. Copeland, NCI'; Lee et
al., 2001) into the SacII site of pCS2+MTeGFP (gift of D. Turner, Univ. Mich.).
There is a SV40 polyA addition sequence just downstream of the EGFP open
reading frame. The resulting 2.4 kb PCR product was gel-purified using a
Qiaquick gel extraction kit (Qiagen) and DpnI-treated to remove template
plasmid before use for homologous recombination.
BAC recombination was performed following the protocol of Lee et al.
(2001). Double-resistant colonies (CmR KanR) were assayed for homologous
recombination by PCR using the following primers: F1 (5′-GCTGTCTCT-
CCTCCCCTCTCTAATG-3′), F2 (5′-GCACCATCTTCTTCAAGGACGAC-
3′), R1 (5′-CCTTGAAGAAGATGGTGCG-3′), and R2 (5′-GGGGGTAT-
GAGTTACAGGATTGG-3′). The kanamycin cassette was flipped out by
induction of flipase, and the cells were screened for kanamycin sensitivity
(KanS). In these colonies, removal of the kanamycin cassette was verified by
PCR using the F1, F2, R1, and R2 primers. The overall structure of the modified
BACs was examined by fingerprint analysis using BamHI and compared to that
obtained for the unmodified BAC. The sequence of the targeted region was
verified by automated sequencing of both DNA strands using primer F1 for the
5′ junction and primer F2 for the 3′ junction.
Generation of BAC-transgenic mice
Transgenic mice were generated from pronuclear injection of closed circular
BAC DNA into mouse oocytes (Copeland et al., 2001; Gong et al., 2002, 2003).
Mice carrying the BAC transgene were genotyped by PCR using tail DNA and
primers to detect the EGFP reporter cassette (forward primer, located in Pax6
intron 3, 5′-GCAAGTTTTATGGTGCTGTTTTGG-3′; reverse primer, located
in EGFP, 5′-CCTTGAAGAAGATGGTGCG-3′; the PCR product is 714 bp).
Three out of twenty-one pups derived from pronuclear injection harbored the
BAC transgene. F1 founders were generated by crossing founder males (lines 3
and 14) or a founder female (line 15) to CD-1 mice (Charles River Laboratories).
These lines are being maintained in the CD-1 background. Transgene copy
number was determined by densitometric analysis of Southern blots performed
on a G4 PowerMacintosh computer running OSX using ImageJ (v1.33,
developed at the U.S. National Institutes of Health; available on the Internet at
http://rsb.info.nih.gov/ij/index.html). Small eye mice harboring the Pax6 BAC
293d08-E4-EGFP pA transgene were generated by crossing an F1 founder male
(line 15) with SeyNeu females. The founder SeyNeu mice for our colony were
generously provided by Dr. Nadean Brown and are maintained in the albino
FVB/N background.
Analysis of transgene expression in whole mouse embryos
Mouse embryos were obtained from our breeding colony, with noon on the
day of plug discovery designated as day 0.5 (E0.5). The pregnant females were
killed using CO2, and the uteri were washed in ice-cold phosphate-buffered
saline (PBS). The embryos were dissected free and placed in ice-cold PBS. GFP
expression was assessed in live embryos by fluorescence microscopy using a
Zeiss Stemi SV11 Apo dissecting microscope fitted for epifluorescence and
documented using a Zeiss AxioCam digital camera or 35 mm SLR camera. All
embryos were then fixed by immersion in 4% paraformaldehyde/PBS at 4°C.
Embryos that were to be used for immunohistochemistry were kept in fixative
for up to 2 weeks at 4°C. Embryos that were to be used for mRNA in situ
hybridization had incisions made in their hindbrain and cerebral vesicles prior to
fixation; these embryos were fixed overnight, dehydrated stepwise through a
graded PBS/methanol series, and stored in methanol at −20°C.
Transgene expression was analyzed in wild-type embryos obtained by timed
matings of transgenic males with non-transgenic CD-1 females (Charles River
Laboratories). Non-transgenic littermates were used as controls. Transgene
expression was analyzed in Sey mutant embryos obtained by intercrossesbetween mice compound heterozygous for the transgene and the Pax6SeyNeu
allele; non-transgenic littermates were used as controls. The genotype of each
embryo was determined by PCR (Xu et al., 1997), using tail or extra-embryonic
membrane DNA (Laird et al., 1991).
Immunocytochemistry
Immunostaining was performed on frozen sections using antibodies against
Pax6 and secondary antibodies conjugated to Cy3 (Jackson ImmunoResearch).
The Pax6 protein was detected using a Pax6 rabbit antisera against a 17-residue
C-terminal peptide from the mouse Pax6 sequence (Mastick et al., 1997). For
sectioning, fixed embryos were embedded in gelatin and cryosectioned (Mastick
et al., 1997); this method did not affect GFP fluorescence. The tissue was
blocked for 1 h using 4% milk, TST (4% nonfat powdered milk dissolved in 10
mM Tris–HCl, pH 7.4, 150 mM NaCl, 0.1% Tween-20) and then incubated
overnight with α-Pax6 antibody diluted 1:1000 in 4% milk, TST. After several
washes in TST, the slides were incubated for 30 min with biotinylated secondary
antibody (Jackson) at 1:100 dilution followed by Cy3-conjugated Streptavidin
(Jackson) at 1:200 dilution for 15 min. Specific signal was detected by either
standard fluorescence microscopy or laser scanning confocal microscopy.
In situ hybridization
Whole-mount mRNA in situ hybridization was performed as described
(Hargrave and Koopman, 2000). Sense and antisense digoxigenin-labeled RNA
probes were prepared from a BglII digest of the pMPX2-1 Pax6 cDNA clone
(gift of T. Glaser, Univ. Michigan) using a DIG RNA labeling kit (Roche).
Hybridization and stringent posthybridization wash steps were performed at
70°C. After color development, embryos were destained for up to 4 h in 1%
Triton X-100/PBS and then postfixed in 4% paraformaldehyde/PBS at 4°C.
Western analysis
Western analysis was performed following standard protocols (Harlow and
Lane, 1988; Sambrook and Russell, 2001). Protein extracts were prepared from
the heads or dissected eyes of both transgenic and non-transgenic E10.5 mouse
embryos. Blots were probed using α-GFP (A-11122, Molecular Probes) at a
1:2500 dilution, α-Pax6 (against the C-terminus) at a 1:1000 dilution, or serum
11 (against the paired domain) (Carriere et al., 1993) at a 1:200 dilution. Bands
were visualized by chemiluminescence (ECL, Pierce Co.).
RNA analysis
Total RNA frommouse embryonic tissue was prepared from tissue in TRIzol
reagent (GibcoBRL). RNA was reverse-transcribed for 1 h at 42°C (Super-
scriptII; GibcoBRL). To assess transcript initiation in the eyes of wild-type
embryos, reverse transcription was performed using a primer complementary to
the mouse Pax6 sequence around the stop codon. 5′ RACE (Frohman, 1990)
was performed using primers directed to the homeodomain within exon 8. PCR
products were cloned, sequenced, and compared with genomic DNA. We
recovered 11, 20, and 16 RACE clones corresponding to transcripts that initiated
from P0, P1, and Palpha, respectively. No clones were recovered that
corresponded to transcripts that initiated from P4.Results
The Pax6–Elp4 locus is directly comparable between humans
and mice
To construct a BAC transgene that contained all known cis
regulatory elements implicated in controlling Pax6 expression
in the eye as well as remote 3′ elements located in the DRR, it
was necessary to first compare the Pax6 locus between mice and
humans. Whereas several eye-specific regulatory elements 5′
489J. Kim, J.D. Lauderdale / Developmental Biology 292 (2006) 486–505and internal to Pax6 have been identified in mouse (Kammandel
et al., 1999; Williams et al., 1998; Xu et al., 1999), the locations
of 3′ regulatory elements, including the minimal extent of the
DRR, have been defined using the human PAX6 locus (Griffin et
al., 2002; Kleinjan et al., 2001). Therefore, to provide a
framework for our BAC studies, we determined the organiza-
tion of the Pax6 locus in mouse and compared it to human.
Scale diagrams of human and mouse Pax6 gene are presented in
Figs. 1A and B.
In both mice and humans, the Pax6 gene has 16 exons
distributed over the ∼30 kb region; in addition to exons 0
through 13, there are also exons alpha and 5a (Glaser et al.,
1992; Kammandel et al., 1999; Plaza et al., 1999; St-Onge et al.,
1997; Williams et al., 1998; Xu et al., 1999) (see also, Fig.Fig. 1. Identification of mouse BACs likely to recapitulate Pax6 expression in the eye
and ELP4, which are in an antisense orientation relative to each other. Bent arrows
boxes denote exons. The breakpoints of the two distal-most aniridia-associated re
indicated by “SGL” and “SIMO” (Fantes et al., 1995; Fukushima et al., 1993; Sim
transgenic reporter assays are indicated for the surface ectoderm (se), neural retina (nr
and RPE (Griffin et al., 2002; Kammandel et al., 1999; Kleinjan et al., 2001, 2004; Wi
Box 123 regulatory region, which includes a regulatory element for the neural retin
transgenic mice, Y593, but not Y589, rescues the mouse Sey phenotype and homozyg
define the DRR for the human PAX6 locus. (B) Physical map of the Pax6/Elp4 locus
upstream of the conserved surface ectoderm regulatory element in humans and mice.
the murine Pax6/Elp4 locus is more compact. Scale bar in panel A applies to panel
432m12 is 189 kb in length and extends from 51.4 kb 5′ of Pax6 exon 0 to just dista
Pax6 exon 0 to within 0.6 kb of Elp4 exon 7. (C) MLAGAN alignments of genom
Z86001, AL136384), mouse (Al512589, AL590380), and chicken (AC14046, AC141
at least 40 bp. Noncoding sequences are shaded in pink; ELP4 exons are shaded in blu
(pink), RNA (purple), DNA (orange), Other (yellow). Twelve single-copy, noncoding
chicken. Of these, four (*) were also conserved with the zebrafish Pax6a locus (AL9
regulatory activity.10A). Transcription of Pax6 initiates from four promoters, here
designated as P0, P1, Palpha, and P4 (Figs. 1A, B) (Kammandel et
al., 1999; Kleinjan et al., 2004; Plaza et al., 1999; Xu and
Saunders, 1997; Xu et al., 1999). P0 and P1 are located 5′ to
exons 0 and 1, respectively. Palpha is located 5′ to the alpha
exon, which is located between exon 4 and 5. P4 is located in the
intron between exon 7 and 8. P0 and P1 constitute the major
promoters and initiate expression in most cell types that express
Pax6 (Anderson et al., 2002; Kammandel et al., 1999; Plaza et
al., 1999; Xu and Saunders, 1997; Xu et al., 1999). Modular cis
regulatory elements controlling Pax6 transcription in the eye
have been defined within a ∼25 kb 5′ region of mouse Pax6.
Specific enhancers for the retina, lens, and cornea have been
identified 5′ to P0, Palpha, and P4 (Kammandel et al., 1999;. (A) Physical map of human chromosome 11p13 showing the locations of PAX6
denote the locations of transcript initiation and direction of transcription; black
arrangements, which disrupt 11p13 but spare the PAX6 transcription unit, are
ola et al., 1983). The locations of eye-specific regulatory elements defined by
), lens (l), and a retina (r) enhancer that drives expression in both the neural retina
lliams et al., 1998; Xu et al., 1999). “Box 123” denotes the location of the C1170/
a (Griffin et al., 2002). The 3′ ends of YACs Y593 and Y589 are indicated. In
ous Sey lethality (Kleinjan et al., 2001; Schedl et al., 1996). Together, these data
on mouse chromosome 2. A differentially methylated CpG island (¥) is located
Comparison of homologous sequences between humans and mice revealed that
B. Mouse BACs 432m12 and 293d08 were identified by library screen. BAC
l to Elp4 exon 8. BAC 293d08 is 160 kb in length and extends from 12 kb 5′ of
ic sequence spanning SIMO to ELP4 exon 7 for human (Z83308, AC131571,
860). Colored peaks represent regions of sequence conservation above 50% over
e. Repetitive sequences are marked as follows: LINE (red), SINE (green), LTRs
regions (arrows) exhibited N75% sequence identity between human, mouse, and
29172). This high density of conserved sequences suggests that this region has
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location of the surface ectodermal (“se”) enhancer, which is the
5′ most eye enhancer and regulates lens and cornea expression
(Kammandel et al., 1999; Williams et al., 1998; Xu et al., 1999),
is indicated for both human and mouse (Figs. 1A and B). In
humans, additional eye enhancers have been defined in two 3′
distal regions, the C1170/Box 123 and DRR, which are located
∼76 kb and N124 kb downstream from Pax6 exon 13,
respectively (Fig. 1A) (Griffin et al., 2002; Kleinjan et al.,
2001). A conserved, differentially methylated CpG island is
located 5′ to P0 in both human and mouse (Figs. 1A, B).
Because the methylation state of this island correlates with Pax6
transcriptional activity (Lauderdale and Glaser, unpublished)
and is located upstream of all known Pax6 regulatory elements,
we have tentatively designated this CpG island as the 5′-most
extent of the Pax6 locus.
Another gene, Elp4, is located 3′ to Pax6 and is arranged in
antisense orientation (Figs. 1A, B) (Kleinjan et al., 2001, 2002).
Elp4 encodes a subunit of the RNA polymerase II elongator
holoenzyme (Winkler et al., 2001). Elp4 has 10 exons with exon
10 located adjacent to Pax6 exon 13 (Fig. 1). Whereas in
humans, ELP4 exons are distributed over a ∼277 kb region, in
mice, they are distributed over an ∼202 kb region (compare
Figs. 1A to B). Although ELP4 is disrupted by aniridia-
associated rearrangements 3′ to PAX6 (e.g. “SGL” and “SIMO”
in Fig. 1A) (Kleinjan et al., 2001, 2002; Lauderdale et al.,
2000), it is not thought to be causal for aniridia (Kleinjan et al.,
2002). Because 3′ Pax6 regulatory elements are located within
Elp4 introns, we include it here to provide reference points
between the mouse and human genomes. Although the Pax6–
Elp4 genes are more compact in mice (compare Fig. 1Awith B),
the structures of the Pax6 and Elp4 genes are highly conserved
between mice and humans.
Defining the location the Pax6 DRR
The DRR is genetically defined for human PAX6 as the ∼75
kb genomic region between the SIMO breakpoint and the
telomeric end of human YAC Y593, which is near ELP4 exon 4
(Fig. 1A). Although elements controlling expression in the lens
and retina (“l” and “r” in Fig. 1A) have been defined by classic
transgenic assay at the PAX6-proximal end of the DRR
(Kleinjan et al., 2001), it is not known if these elements are
sufficient for DRR eye activity. To narrow the region likely to
functionally constitute the DRR, we took a comparative
genomics approach to identify evolutionarily conserved non-
coding sequences within the genomic region extending from
SIMO to the telomeric end-point of Y593 (Fig. 1A). Fig. 1C
shows the results of a comparison between humans, mouse and
chicken Pax6 genomic DNA sequences using the multi-
LAGAN computer program (Brudno et al., 2003) and displayed
using the VISTA computer program (Dubchak et al., 2000;
Frazer et al., 2004; Mayor et al., 2000). This analysis revealed
14 regions of single-copy, noncoding genomic DNA sequence
with N75% nucleotide identity shared between human, mouse,
and chicken. The first of these regions corresponded with the
position of the SIMO breakpoint (“SIMO” in Fig. 1C), whichhad been previously shown by cross-species Southern analysis
to be conserved between mammals and birds (Gessler et al.,
1989). The next eleven regions were located between the
position of the SIMO breakpoint and ELP4 exon 7 (peaks 2–12
in Fig. 1C). The last two regions were located between ELP4
exon 4 and 7 (data not shown). We extended these analyses
using genomic sequences from pig (Sus scrofa), opossum
(Didelphis virginiana and Monodelphis domestica), platypus
(Ornithorhynchus anatinus), and zebrafish (Danio rerio). We
found that regions 1–12 were similarly conserved in these
mammals and regions 2, 4, 5, and 7 had N75% sequence
conservation with the zebrafish Pax6a locus on linkage group
25 (data not shown). This high-density cluster of evolutionarily
conserved, single-copy, non-coding sequences suggested that
clusters of functionally important regulatory elements are
located between SIMO and ELP4 exon 7.
Identification of BACs likely to recapitulate Pax6 expression in
the eye
To test if the mouse genomic region extending from the
differentially methylated CpG island 5′ of P0 through Elp4
exon 7 was sufficient to drive transgene expression in the
Pax6 expression pattern, we isolated two mouse genomic
DNA BACs, BAC 432m12 and BAC 293d08, that each
contains the Pax6 transcript unit and sequences homologous
to SIMO. The end points of each BAC were determined by
BAC end sequencing and alignment to mouse genomic DNA
(Fig. 1B). BAC 432m12 is 189 kb in length and extends from
51.4 kb 5′ of Pax6 exon 0 to just distal to Elp4 exon 8. BAC
293d08 is 160 kb in length and extends from 12 kb 5′ of Pax6
exon 0 to within 0.6 kb of Elp4 exon 7 and contains the
twelve conserved, non-coding sequences identified above. To
verify that the BACs contain contiguous genomic DNA that
spans the Pax6 locus, internal structures were determined by
restriction or “fingerprint” analysis (Gong et al., 2003) using
BamHI or EcoRI digests. The patterns and sizes of the
restriction fragments for each BAC were compared in
ethidium-stained gels. Selected fragments were compared to
the endogenous Pax6 locus using digests of genomic DNA
prepared from 129/SvJ mice in Southern blots. With the
exception of BAC end fragments, restriction fragment sizes
were comparable both between BACs and also with the
endogenous locus (data not shown). Thus, BACs 432m12 and
293d08 are intact Pax6 genomic clones. Because BAC
293d08 includes the 5′ differentially methylated CpG island
plus the DRR region between SIMO and Elp4 exon 7, we
chose this BAC to use as a transgene in mice.
Generation and molecular analysis of transgenic mice
To facilitate expression analysis and remove Pax6 function
from the BAC transgene, we inserted an enhanced green
fluorescent protein reporter cassette (EGFP pA) in-frame with
the initiator ATG of Pax6 exon 4 (Figs. 2A, B) using the
prophage BAC modification system (Lee et al., 2001; Yu et
al., 2000). Because P0 and P1 constitute the major promoters
Fig. 2. Construction of the Pax6 BAC 293d08-E4-EGFP pA reporter transgene. (A) Mouse BAC 293d08 was modified by insertion of a green fluorescent protein
reporter cassette (EGFP pA) in-frame with the initiator ATG of Pax6 in exon 4 using a prophage BAC modification system (Lee et al., 2001; Yu et al., 2000). The
EGFP pA reporter cassette was inserted such that the remaining 7 bp of exon 4 and the first 8 bp of the intron were deleted (CAGAACA/gtaagtgt). The targeting
construct contained the EGFP-SV40 pA reporter cassette and the kanamycin resistance (KanR) gene flanked by FRT sequences. After homologous recombination, the
kanamycin cassette was subsequently flipped out by induction of flipase. Bacteria harboring the modified BAC were identified by resistance to chloramphenicol
(CmR) and sensitivity to kanamycin (KanS). (B) Sequence of the targeted Pax6 exon 4 in BAC 293d08-E4-EGFP pA. The EGFP coding sequence is in-frame with the
initiator ATG of Pax6; the sequence 5′ of EGFP is that of Pax6. (C) BamHI restriction analyses of the targeted BAC. The EGFP pA cassette introduced a novel BamHI
site (B*) 3′ to the endogenous BamHI site of Pax6 exon 4, which resulted in a novel 970 bp fragment in the targeted BAC (arrowhead) and a 100 bp increase in the
adjacent 3′ 10.2 kb BamHI fragment (location denoted by arrow). No other changes were observed. B, BamHI site.
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express Pax6 (Anderson et al., 2002; Kammandel et al., 1999;
Plaza et al., 1999; Xu and Saunders, 1997; Xu et al., 1999),
placement of the EGFP reporter cassette in exon 4 was
expected to prevent translation of Pax6 from the majority of
transcripts initiating from the BAC. This was necessary
because Pax6 transcripts initiating from the unmodified BAC
would increase the amount of Pax6 protein in the mouse,
which would be expected to affect the development of the eye
as was observed for mice harboring the human Y593
transgene (Schedl et al., 1996). We targeted exon 4 such
that the remaining 7 bp of exon 4 and the first 8 bp of the
following intron (CAGAACA/gtaagtgt) were deleted. No
other intronic sequences were affected. Restriction fingerprint
and sequence analyses revealed that the EGFP pA reporter
cassette was correctly inserted into Pax6 exon 4 of BAC
293d08 and that no other changes to the BAC were made
(Figs. 2B, C).
Three independent lines of transgenic mice (lines 3, 14,
and 15) were generated by pronuclear injection of closed
circular BAC DNA into mouse oocytes (Copeland et al.,
2001; Gong et al., 2002, 2003). Hybridization with an intron 3
probe (Fig. 3A) as well as PCR analysis with BAC vector armprimers (data not shown) confirmed that the BACs were intact
in the three lines of transgenic mice. Transgene copy number
was determined by densitometric analysis of EcoRI fragments
detected in a Southern blot (Fig. 3A). Because the probe
detected both an endogenous Pax6 genomic fragment and a
fragment from the BAC transgene, the endogenous fragment
was used as an internal normalization standard for two gene
copies. Mouse line 3 harbors 10 ± 1 copies, line 14 harbors 1
copy, and line 15 harbors 8 ± 1 copies of the transgene (n = 3
independent blots).
Although the placement of the EGFP reporter cassette in
exon 4 was expected to prevent translation of Pax6 from the
majority of transcripts initiating from the BAC, Pax6 isoforms
could potentially be translated from transcripts initiating from
either the Palpha or P4 promoters, or from alternatively spliced P0-
and P1-initiated transcripts that lack exon 4, which have been
recently described (Gorlov and Saunders, 2002). Because eye
development is a very sensitive change in Pax6 dosage, we
tested by Western analysis if the BAC transgene acted as a
significant source of Pax6 protein. First, we tested if the BAC
produced an EGFP-Pax6 fusion protein by probing protein
extracts prepared from the heads of either wild-type embryos or
BAC-transgenic embryos from line 3 or 15. Both Pax6 protein
Fig. 3. Molecular analysis of the BAC 293d08-E4-EGFP pA transgene in mice. (A) Southern analysis of EcoRI-digested genomic DNA using a 32P-labeled probe. A 4
kb EcoRI fragment is detected in mice harboring the transgene (lines 3, 14 and 15), but not in wild-type (WT) animals. Densitometric analysis, using the 3 kb EcoRI
fragment from the endogenous gene as a reference, indicates that mouse line 3 harbors 10 ± 1 copies, line 14 harbors 1 copy, and line 15 harbors 8 ± 1 copies of the
transgene. (B) Western analysis using protein extracted from the heads of E10.5 embryos. Antibodies to EGFP detected a single band of 27 kDa in animals harboring
the transgene, suggesting that the EGFP reporter was not expressed as a fusion protein. Although the band in the WT;Tg lane appears slightly retarded relative to the
control, this slight shift was not observed in other blots. Blots probed with α-Pax6 revealed comparable Pax6 expression between wild-type and wild-type transgenic
embryos; no Pax6 protein was detected in extracts prepared from homozygous Seymutant embryos harboring the transgene. Together, these data suggest that the Pax6
BAC 293d08-E4-EGFP pA transgene does not significantly alter the levels of Pax6 protein in the developing embryo. Both the α-GFP and α-Pax6 panels are from the
same blot. The location of the SeyNeu truncation and the epitope recognized by α-Pax6 are indicated on the schematic of the Pax6 protein.
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EGFP-Pax6 fusion protein was detected in embryos harboring
the BAC transgene by either the α-GFP or the α-Pax6 (Mastick
et al., 1997) antibodies (Fig. 3B), indicating that there was no
read-through of P0- or P1-initiated transcripts. In fact, compar-
able results between wild-type and transgenic embryos wereobtained using the α-Pax6 antisera, indicating that multiple
copies of the BAC transgene did not significantly affect Pax6
protein levels in wild-type embryos harboring the transgene. To
directly test if the BAC was a source of Pax6 protein, we probed
extracts prepared from the heads of SeyNeu mutant embryos
harboring 8 copies of the BAC transgene. The SeyNeu allele
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domain (Hill et al., 1991) that is normally recognized by the α-
Pax6 antisera used (Fig. 3B). Therefore, any Pax6 protein
detectable in extracts prepared from BAC-transgenic SeyNeu
homozygous mutant embryos would have originated from the
BAC. Since no Pax6 protein was detected, we conclude that the
Pax6 BAC 293d08-E4-EGFP pA transgene is not a significant
source of Pax6 protein in the developing embryo. However,
there may be subdomains of expression not detectable in whole-
head extracts.
The BAC transgene expresses EGFP in a Pax6 expression
pattern in most tissues
We examined transgenic animals for EGFP fluorescence at
different stages of development and also in the adult brain (Fig. 4
and data not shown). Comparisons of EGFP fluorescence
between live and fixed embryos revealed identical patterns of
expression; however, the background fluorescence was higher in
the fixed tissues. Although lines 3, 14, and 15 all exhibited EGFP
expression patterns identical toPax6 (Figs. 4D, E, G), lines 3 and
15 have the brightest fluorescence that exactly correlates with
transgene copy number. In lines 3 and 15, EGFP fluorescenceFig. 4. The BAC transgene exhibits Pax6-like expression in most tissues. Unless
respectively, of an E7.5 embryo (side-view). No EGFP expression was observed at E7
is observed in the neural ectoderm of the presumptive forebrain, optic pit (op), presu
Front view, 11 somites, embryo different from the one shown in panel B. EGFP is
expressed in the neural ectoderm of the presumptive forebrain, optic pit, presumptive
situ hybridization. Arrowheads denote expression in hindbrain and spinal cord. (D–H
(cv), developing eye (ey) and nose (np), hindbrain (hb), and spinal cord (sc). In contra
is observed in the ventral thalamus (vt) and in a ventral cluster of cells (vc) at the prete
thalamus (dt). (F) EGFP expressed in the pancreas (p). (G) Although EGFP express
expression is similar to lines 3 and 15, which harbor 10 and 8 copies of the transg
vesicles, olfactory bulb (ob), and eye. (J) EGFP expression is observed in the cortex
visible through the skull.was first detected in the presumptive forebrain at E8.0, and by
E8.5, robust EGFP expression was observed in the presumptive
forebrain, hindbrain, and anterior spinal cord adjacent to somites
(Fig. 4B). Within the forebrain, EGFP was strongly expressed in
the optic pit (Fig. 4B″). No EGFP fluorescence was observed in
E7.5 embryos (Fig. 4A). This expression pattern is directly
comparable to Pax6 mRNA in situ hybridization (Fig. 4C)
(Grindley et al., 1995; Walther and Gruss, 1991).
However, some differences between EGFP and Pax6
expression were observed at E9.5. Whereas a Pax6 pattern of
EGFP expression was observed in the cerebral vesicles, eye,
nasal pit, hindbrain, spinal cord, and endocrine pancreas (Figs.
4D–G), only a partial pattern was observed in the diencephalon.
Although Pax6 mRNA is strongly expressed in the dorsal
diencephalon at E10.5 (Fig. 8A), EGFP was only expressed in
two patches of cells: one located in the ventral thalamus (vt) and
the other in the ventrocaudal pretectum (Figs. 4D′, G). With the
exception of the diencephalon, a Pax6 pattern of EGFP
expression was observed in the embryo at both E12.5 (Fig.
4H) and E15 (Fig. 4I). At E15, strong EGFP expression was
observed in the cerebral vesicles, olfactory bulb, and eye (Fig.
4I). EGFP continued to be expressed in the eye and cortex of
postnatal and adult mice (Fig. 4J, data not shown). These resultsindicated, data are from line 15. (A, A′) Bright field and fluorescent images,
.5. EGFP fluorescence is first detected at E8.0. (B, B′) E8.5. EGFP fluorescence
mptive hindbrain (hb), and presumptive spinal cord adjacent to somites (s). (B″)
expressed in both the neural ectoderm (ne) and optic pit. (C) At E8.5, Pax6 is
hindbrain, and presumptive spinal cord as visualized by whole-mount mRNA in
) A Pax6-like pattern of EGFP fluorescence is observed in the cerebral vesicles
st, only a partial Pax6 pattern is observed in the diencephalon. EGFP expression
ctal/mesencephalic (pt/mes) boundary. No EGFP expression is observed in dorsal
ion is less robust in line 14, which has one copy of the transgene, the pattern of
ene, respectively. (I) E15. Strong EGFP expression is observed in the cerebral
(ctx), olfactory bulb, and eyes of a 3-day-old pup. The expression in the brain is
Fig. 5. BAC 293d08 faithfully replicates Pax6 expression in the developing eye.
Sections cut through the eye of transgenic mouse embryos at E10.5 (A–C) or
E13.5 (D–F). (A, D) EGFP fluorescence. (B, E) Endogenous Pax6 visualized by
indirect immunofluorescence (red). (C, F) Merged images. EGFP and Pax6 are
coexpressed in the cells in the cerebral vesicles, neural retina (nr), retinal
pigmented epithelium (rpe), developing lens, and presumptive cornea. At E13.5,
EGFP expression in retinal ganglion cells axons is visible within the optic nerve
(on).
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expression pattern in all regions of the developing mouse, except
the diencephalon.Fig. 6. BAC 293d08 replicates Pax6 expression in the adult eye. Sections cut throu
expressed by cells in the corneal epithelium, iris, ciliary body, and retina. The EGFP
structure. (B) In the retina, EGFP and Pax6 are both expressed by cells in the ganglion
amacrine cells and Müller glia. EGFP expression in Müller glia is evident in the radBAC 293d08 faithfully replicates Pax6 expression in the eye
Our analysis of transgene expression in whole embryos
revealed that the BAC transgene was expressed in the
developing eye during oculogenesis. We further examined
EGFP expression in cryosections cut through the eye at different
stages of development to verify at the cellular level its
faithfulness to the endogenous Pax6 pattern. Sections through
E10.5 optic vesicles revealed EGFP expression in the
neuroepithelial cells of the optic vesicle and the overlying
surface ectoderm. EGFP is expressed in the neural retina, RPE,
lens, and presumptive cornea identically to Pax6 protein (Figs.
5A, D). Within the developing retina, both retinal ganglion cells
(RGCs) and amacrine cells express EGFP (Fig. 5D, data not
shown). EGFP expression in the RGC axons is evident in the
optic nerve (Fig. 5D).
To directly compare cells expressing EGFP with those
expressing Pax6, sections were immunolabeled in red for Pax6
using the α-Pax6 antisera described above. Pax6 protein is
nuclear, but EGFP is predominantly cytoplasmic. Consequently,
at high magnification, double-labeled cells contained red nuclei
surrounded by green cytoplasm. Comparison of Pax6 expres-
sion (Figs. 5B, E) with EGFP (Figs. 5A, D) revealed coincident
expression in all eye tissues at both E10.5 (Fig. 5C) and at E13.5
(Fig. 5F).
We next directly compared cells expressing EGFP with those
expressing Pax6 in sections cut through the adult eye (Fig. 6).
Just as in the developing eye, comparison of Pax6 expression
with EGFP revealed coincident expression in the retina,
including the RGCs, amacrine cells, and Müller glia (Fig.
6B). EGFP expression in the Müller glia is evident in the radial
processes spanning the outer nuclear layer (ONL). Coincident
expression of Pax6 and EGFP was also observed in the corneal
epithelium, iris, and ciliary body (Fig. 6A). The greengh the eye of a transgenic mouse. (A) Anterior eye. EGFP and Pax6 are both
fluorescence in the lens is the result of this protein being incorporated into this
cell layer (GCL) and a subset of cells in the inner nuclear layer (INL), including
ial processes spanning the outer nuclear layer (ONL).
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has been incorporated into this structure. Thus, transgene
expression in both the developing and adult eye replicates Pax6
expression with high fidelity.
Transgene expression in the developing olfactory epithelium
and bulb
Pax6 also plays a key role in the development of the sense of
smell (Martha et al., 1995; Sisodiya et al., 2001). To determine
if the transgene was expressed in a Pax6 pattern within the
developing olfactory system, we examined EGFP expression in
cryosections cut through the developing olfactory epithelium
and bulb. Only cells coexpressing EGFP and Pax6 were
observed in the olfactory placode at E9.5 and in the olfactory
epithelium at E10.5 and E13.5 (Fig. 7A, data not shown).
The olfactory bulb (OB) develops at the rostral end of the
telencephalon and functions as the primary processing center
for odor information. Over 80% of the cells produced in the
olfactory bulb primordium between E11 and E13 migrateFig. 7. Transgene expression in the developing olfactory system. Sections cut
through the olfactory epithelium (A–C) or olfactory bulb primordium (D–F) of
transgenic mouse embryos at E13.5. (A, D) EGFP fluorescence. (B, E)
Endogenous Pax6 visualized by indirect immunofluorescence (red). (C, F)
Merged images. (A–C) Cells in the olfactory epithelium coexpress EGFP and
Pax6. (E) Within the rostral telencephalon, cells expressing Pax6 are located in
the ventricular zone of the olfactory bulb, in a medial stripe (ms) near the
midline, and in a lateral stripe (ls) in the region of the developing lateral
olfactory tract (LOT). (D) EGFP-expressing cells are also in the ventricular zone
of the olfactory bulb and in both the medial and lateral stripes. EGFP-positive
axons are observed within the LOT. Arrows denote the lateral extent of the LOT.
(F) Whereas cells coexpressing EGFP and Pax6 are located in the ventricular
zone of the olfactory bulb, more Pax6-expressing cells than EGFP-expressing
cells are observed in the lateral stripe. This suggests that cells within the
olfactory bulb primordium differentially regulate Pax6 expression.radially out of the ventricular zone and differentiate as mitral
cells (Hinds, 1968). These cells, along with the tufted cells,
which are born between E13 and E18 (Hinds, 1968), establish
the lateral olfactory tract, which is located at the lateral edge of
the telencephalon (Ramón y Cajal, 1890; Hinds, 1972; Lopez-
Mascaraque and de Castro, 2002; Valverde-García, 1965). At
E13.5, three groups of Pax6-expressing cells were observed in
the olfactory bulb region (Fig. 7E). One population was located
in the ventricular zone of the OB, and two populations were
located in the mantle region. The cells in the mantle were in two
stripes, one located medially and the other located laterally (MS
and LS, respectively; Fig. 7E). Cells in the lateral stripe were in
the region of the lateral olfactory tract (LOT).
EGFP was also expressed in these regions and in axons in the
LOT (Fig. 7D). The LOT was visualized by double-labeling
with βIII tubulin (data not shown), which labels axons in the
CNS (Lee et al., 1990a,b; Moody et al., 1989, 1996). Direct
comparison of Pax6 and EGFP expression revealed that most, if
not all, Pax6-expressing cells within the olfactory bulb and
medial stripe coexpressed EGFP (Fig. 7F). However, both
Pax6+/EGFP+ and Pax6+/EGFP− cells were located in the
lateral stripe. Whereas most, if not all, cells near the olfactory
bulb primordium coexpressed Pax6 and EGFP, cells located in
the region denoted by the arrowhead in Fig. 7E expressed Pax6
but not EGFP. These results suggest that different mechanisms
control Pax6 expression in the cells in the ventricular zone of
the olfactory bulb relative to the population of cells in the
mantle region. Alternatively, because cells are known to migrate
into the embryonic olfactory bulb from other brain regions
(Wichterle et al., 2001), it is possible that the Pax6+/EGFP−
cells in mantle originated in a different part of the forebrain.
Transgene expression in the diencephalon exhibits a partial
Pax6 pattern
In all three lines of transgenic mice, expression of the BAC
293d08 transgene did not match the pattern expected for Pax6 in
the diencephalon. By E10.5, the diencephalon can be divided
into three regions: the presumptive dorsal thalamus (dt), the
presumptive ventral thalamus (vt), and the pretectum (pt)
(Puelles and Rubenstein, 1993; Stoykova et al., 1996). At this
time, Pax6 mRNA is expressed by a broad swath of cells
located in the dorsal diencephalon and ventrally in a large patch
of cells in the ventral thalamus (Fig. 8A). Pax6 is also expressed
in a ventrocaudal group of cells located at the pretectum/
mesencephalon (pt/mes) boundary (Mastick et al., 1997). In
contrast with Pax6 mRNA, EGFP is only expressed by a patch
of cells located in the ventral thalamus and by a ventrocaudal
cluster of cells in the pretectum (Fig. 8B). No EGFP expression
was detected in the dorsal diencephalon (Fig. 8B). This finding
was unexpected because this BAC contains all previously
identified diencephalic regulatory elements, which have been
shown by transgenic assays to drive reporter gene expression in
the dorsal diencephalon (Griffin et al., 2002; Kleinjan et al.,
2001, 2004).
To examine if the transgene was expressed in a partial Pax6
pattern within the diencephalon, we directly compared EGFP
Fig. 8. Transgene expression in the diencephalon exhibits a partial Pax6 pattern. (A) At E10.5, Pax6 is broadly expressed in the diencephalon as visualized by whole-
mount mRNA in situ hybridization. The diencephalon can be divided into three regions, the pretectum (pt), dorsal thalamus (dt), and ventral thalamus (vt). Pax6
mRNA is expressed in all three of these regions and in a cluster of cells (vc) in the ventral pretectum at the pt/mes boundary. (B) In contrast, EGFP expression in the
diencephalon is restricted to the ventral thalamus and the ventral cluster in the pretectum, suggesting that the transgene is expressed in only a subset of Pax6 expression
domains. (D–F) Section through the diencephalon at E10.5; the plane of section shown in panel B. (E) Pax6, visualized by immunofluorescence, is expressed
throughout the diencephalon and terminates in a sharp border at the pt/mes boundary. (D) EGFP is expressed by a narrow stripe of cells at the pt/mes boundary. (F)
Direct comparison reveals that the cells at the pt/mes boundary coexpress EGFP and Pax6. (G–L) Section through the diencephalon at E13.5; plane of section shown in
panel C. These panels are photomosaics, which show the thalamic region. (H) Pax6, visualized by immunofluorescence, is expressed by cells in the ventricular zone
(vz) and mantle region of the thalamus (th). Scattered Pax6-expressing cells are also located in the hypothalamus (arrowheads). (G) EGFP is expressed by cells in the
mantle region and the ventricular zone of the ventral thalamus, adjacent to the hypothalamic sulcus (sul). No EGFP-expressing cells were observed in the ventricular
zone adjacent to the interventricular foramen (ivf). EGFP-positive axons were observed along the lateral edge of the thalamus and in bundles adjacent to the ivf. (I)
Direct comparison revealed that all cells that expressed EGFP also expressed Pax6. In contrast, no EGFP was detected in the Pax6-expressing cells located in the
ventricular zone adjacent to the ivf or in the scattered cells in the hypothalamus. (J–L) Cells in the mantle region of the ventral thalamus coexpress EGFP and Pax6
(arrowheads indicate a few such cells). These high-magnification views were taken from a section adjacent to the one shown in panels G–I. Rostral is down in all
sections; mge, medial ganglionic eminence.
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phalons of transgenic embryos at E10.5 (Figs. 8D–F) or E13.5
(Figs. 8G–I; J–L). Cells expressing Pax6 were visualized using
α-Pax6 (Figs. 8E, H, K). At E10.5, Pax6 is broadly expressed inthe diencephalon and sharply terminates at the pt/mes boundary
(arrow, Fig. 8E). In contrast, EGFP expression in the caudal
diencephalon is limited to a stripe at the pt/mes boundary
(arrow, Fig. 8D). Direct comparison of the two expression
Fig. 9. The BAC transgene and Pax6 are coexpressed by cells in hindbrain and
pancreas. Horizontal sections cut through the hindbrain (A–C) or pancreas (D–
F) of transgenic mouse embryos at E10.5. (A, D) EGFP fluorescence. (B, E)
Endogenous Pax6 visualized by indirect immunofluorescence (red). (C, F)
Merged images. Cells in the hindbrain and pancreas coexpress EGFP and Pax6.
otv, otic vesicles.
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subset of the Pax6-expressing cells in the pretectum (Fig. 8F).
However, in the ventral thalamus, most if not all cells that
expressed Pax6 also expressed EGFP (data not shown). These
results suggest that Pax6 expression in the diencephalon is
minimally controlled by at least three different regulatory
mechanisms: one that controls expression in the ventral
thalamus and two that control expression in dorsal thalamus
and pretectum. The mechanism controlling Pax6 expression at
the pt/mes boundary is likely to be involved in establishing this
boundary and is different than the one controlling Pax6
expression in the rest of the dorsal diencephalon.
At E13.5, Pax6 is broadly expressed within the thalamic
region of the diencephalon (Fig. 8H). Cells expressing Pax6 are
located in the ventricular zone and mantle of the thalamus (Fig.
8H), and scattered Pax6-expressing cells are located in the
hypothalamus (arrowheads, Fig. 8H). Expression in the
ventricular zone includes both the dorsal and ventral aspects
of the thalamus and ends within the hypothalamic sulcus, which
demarcates the thalamic/hypothalamic boundary (Fig. 8H).
Within the ventral thalamus, Pax6-positive nuclei are located in
a broad swath extending medially from the ventricular zone
laterally to the superficial edge of the thalamus (Fig. 8H). A
similar pattern of expression is observed for EGFP in the ventral
thalamus (Fig. 8G); however, EGFP is not expressed by cells in
the ventricular zone adjacent to the interventricular foramen
(ivf) nor in the scattered Pax6+ cells in the hypothalamus (Fig.
8I). Although not all Pax6-expressing cells coexpressed EGFP,
direct comparison revealed that most if not all EGFP-expressing
cells in the thalamus expressed Pax6 (Figs. 8I, L). Axon tracts
comprised of EGFP-expressing axons are visible in this section
(Figs. 8G, I). These data demonstrate that the majority of Pax6-
expressing cells in the thalamus also express the BAC
transgene. However, the lack of transgene expression in some
Pax6+ cells in the thalamus is consistent with our observations
in earlier embryos and reinforces the idea that Pax6 expression
in the diencephalon is controlled by different mechanisms in
different cell populations.
The BAC transgene and Pax6 are coexpressed by most cells in
the embryo
Our analysis of transgene expression in whole embryos
revealed that, with the exception of the developing dience-
phalon, the transgene was expressed in a Pax6-like spatio-
temporal expression pattern in the embryo. However, our
analysis of the developing olfactory bulb revealed a population
of Pax6+ cells that, like in the diencephalon, did not coexpress
EGFP, and this discrepancy was not visible in whole mounts.
To investigate if the transgene was only expressed in a subset
of Pax6+ cells in other regions of the embryo, we directly
compared transgene expression with Pax6 in cryosections
through the cerebral vesicles (Fig. 5C), hindbrain (Fig. 9C),
spinal cord (data not shown), and pancreas (Fig. 9F) of E10.5
embryos. In these regions, all cells expressing Pax6 also
express EGFP. In the hindbrain, cells coexpressing EGFP and
Pax6 were observed both in horizontal sections along therostral–caudal axis (Figs. 9A–C) and as well as along the
dorsoventral axis (data not shown). Similar results were
obtained for the spinal cord (data not shown). Cells
coexpressing Pax6 and EGFP were also observed in Rathke's
pouch at E13.5 (data not shown). These results suggest that,
with the exception of the diencephalon and olfactory bulb, this
BAC transgene replicates Pax6 expression.
BAC transgene expression is subject to Pax6 autoregulation
Pax6 transcription in the lens and olfactory placodes and in a
subset of domains within the diencephalon requires Pax6 (Aota
et al., 2003; Grindley et al., 1995; Kleinjan et al., 2004). Does
Pax6 similarly regulate BAC transgene expression? To test this
idea, mice heterozygous for both the transgene and Pax6SeyNeu
allele were produced and mated together to generate Pax6
mutant homozygotes carrying one allele of the transgene (Tg;
Pax6−/−). In these embryos, EGFP expression was observed in
those regions where Pax6 expression is not subject to
autoregulation, including the cerebral vesicles, optic vesicles,
ventral thalamus, hindbrain, spinal cord, and pancreas (Fig.
10D, data not shown). Conversely, no EGFP expression was
observed in those regions that require Pax6 for expression,
including the lens surface ectoderm (Fig. 10E), nasal placodes
(data not shown), and the ventrocaudal cluster of cells at the pt/
mes region (compare 10A with D). These results demonstrate
that BAC transgene expression in these domains is cross-
regulated by Pax6 comparable to autoregulation at the
endogenous gene locus.
Fig. 10. BAC transgene expression in Pax6 mutant embryos. To test if the BAC transgene was subject to regulation by Pax6 and also to identify cells potentially
utilizing the Palpha and/or P4 promoters, mice compound heterozygous for the transgene and the Pax6
SeyNeu allele (Tg;Pax6 +/−) were produced and mated together to
generate Pax6 homozygotes carrying the transgene (Tg;Pax6 −/−). (A–C) E10.5 wild-type littermate carrying the transgene. (D–F) E10.5 Pax6 homozygote carrying
the transgene. (G–I) E10.5 non-transgenic Pax6 homozygote littermate. (J–L) E13.5 Pax6 homozygote carrying the transgene. (A, D, G, J) EGFP expression
visualized in whole embryos; these panels were generated by an overlay of EGFP fluorescence on the corresponding bright field images. (C, F, I, L) Pax6 expression
visualized by immunofluorescence using an α-Pax6 antisera directed towards the C-terminal 17 amino acids of mouse Pax6 (Mastick et al., 1997). (D, E) As in wild-
type embryos, EGFP is expressed in the optic vesicle, cerebral vesicle, presumptive ventral thalamus (vt), hindbrain, spinal cord, and pancreas in Pax6 −/− embryos at
E10.5. In contrast with wild-type littermates, transgene expression is not observed in the nasal pits, lens surface ectoderm (se), or in the ventral cluster (vc) of cells in pt
(compare D with A, E with B), consistent with Pax6 autoregulation in these tissues. (F, I) Interestingly, a Pax6 protein was detected in the optic vesicle of Pax6SeyNeu
mutant embryos harboring the transgene at E10.5 but not in non-transgenic Pax6SeyNeu mutant littermates (compare F with I). This protein is likely due to transcripts
initiating from the Palpha, and/or P4 promoter, located in the BAC transgene. These transcripts are predicted to encode a Pax6 isoform comprised of the homeodomain
and C-terminal domain, but lacking the paired domain. (K, L) Both EGFP and Pax6 immunoreactivities were detected in the olfactory-bulb-like structure (OBLS) and
in scattered cells (arrowheads) in the rostral telencephalon of E13.5 Pax6SeyNeu mutant embryos harboring the transgene.
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express P0/P1 transcripts
The presence within the diencephalon and olfactory bulb of
Pax6+/EGFP− cells could be explained if the BAC transgene
lacked critical regulatory elements required for expression
within these cells. Alternatively, these cells might express Pax6
using only the Palpha and/or P4 promoters. Because the EGFP
reporter would not be contained in transcripts initiating from
these promoters in the transgene, it was possible that Pax6
transcription from the BAC transgene was regulated correctly in
these Pax6+/EGFP− cells but was not detectable using EGFP. To
assess if specific cell types within the embryo expressed Pax6
using the Palpha and/or P4 promoters, cryosections from Tg;
Pax6−/− embryos at E10.5 and E13.5 were stained with α-Pax6
antibody (Figs. 10F, L). Because this antibody recognizes the C-
terminal amino acids of Pax6 (Fig. 3B), it cannot detect the
truncated form of Pax6 protein expressed by the SeyNeu allele
(Fig. 10I). Therefore, any Pax6 protein detected by the antisera
in these mutant embryos would have originated from Palpha- or
P4-initiated transcripts from the BAC transgene. A survey ofsections cut from E10.5 and E13.5 Tg;Pax6−/− embryos
revealed Pax6 immunoreactivity in both the optic vesicle and
rostral telencephalon (Figs. 10F, L); however, these cells also
expressed EGFP (Figs. 10E, K). No Pax6 immunoreactivity was
observed in sections through the cerebral vesicles, hindbrain,
spinal cord, pancreas, or diencephalon at either E10.5 or E13.5
(Fig. 10F, data not shown). These results suggest that Palpha/P4-
initiated transcripts are only expressed in subsets of cells within
the embryo, and, in these cells, Pax6 is also expressed using the
P0 and/or P1 promoters. Therefore, the BAC transgene appears
to be missing a critical regulatory element required for Pax6
expression in a subset of cells in diencephalon and also in the
olfactory bulb.
Identification of a paired-less Pax6 isoform in the eye and
olfactory bulb
The finding of Pax6 immunoreactivity, using the C-terminal
Pax6 antisera, in the optic vesicles of Tg;Pax6−/− embryos at
E10.5 (Fig. 10F) suggested that Palpha- and/or P4-initiated
transcripts are expressed in the developing eye. Although the
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in their development, they are regionalized along their proximo-
distal extent as optic stalk, neural retina, and RPE (Baumer et
al., 2003). In contrast with EGFP expression, which was more
strongly expressed in distal and medial regions and less strongly
expressed in the proximal region (Fig. 10E), Pax6 immunor-
eactivity was strongest in the medial region and exhibited a
sharp border of expression proximally (arrow, Fig. 10F). These
cells coexpress Chx10 (data not shown), a marker for
presumptive neural retina (Baumer et al., 2003; Burmeister et
al., 1996). Pax6 immunoreactivity was also observed in the
optic vesicles of Tg;Pax6−/− embryos at E13.5 (data not
shown). These data suggested that the Palpha and/or P4
promoters were active in the developing retina.
To assess if the Palpha and/or P4 promoters were utilized in
wild-type non-transgenic embryos, a 5′ RACE analysis was
performed using pooled eyes dissected from wild-type embryosFig. 11. Paired-less Pax6 is expressed in the developing eye. (A) 5′ RACE analysis
Forty-seven independent clones were analyzed. Only transcripts initiating from P0, P
Two P1-initiated transcripts used an alternative splice site for exon 2. About half Palph
the alpha exon (*). The ATG in exon 7 denotes three evolutionarily conserved ATGs
between exon 4 and 7. (B–C) Western analysis of extracts prepared from eyes (ey) o
The arrow denotes a 32/33 kDa protein detected using the α-Pax6 antisera (Mastick et
protein was enriched in the eye but not head extracts of both wild-type and transgenic
al., 1993), which is directed towards the paired domain of Pax6. Both α-Pax6 and seru
type embryos the amount of the 32/33 kDa isoform was low relative to the 46 and 4
separation between the 46 and 48 kDa isoforms in all lanes and the 32 and 33 kDa i
Together, these data demonstrate that a paired-less isoform of Pax6 is expressed inbetween E10.5 and E13.5. Forty-seven (47) independent
transcripts were analyzed. Although P4-initiated transcripts
were not detected in this assay, transcripts initiating from P0,
P1, and Palphawere identified (Fig. 11A). Of these, 31 transcripts
initiated from either the P0 or P1 promoters and 16 transcripts
initiated from the Palpha promoter. All of the transcripts that
initiated from the P0 and P1 promoters included exon 4. These
results demonstrate the Palpha promoter is active during eye
development and suggest that Palpha-initiated transcripts repre-
sent a source of Pax6 protein in the developing eye.
Whereas P0- and P1-initiated transcripts encode for a Pax6
protein that includes the paired domain, homeodomain, and PST
domain (Carriere et al., 1993; Glaser et al., 1992; Martin et al.,
1992; Ton et al., 1991;Walther and Gruss, 1991), Palpha-initiated
transcripts are predicted to encode for a Pax6 protein that
includes the homeodomain and PST domain but lacks the paired
domain (Carriere et al., 1993). To directly test if a paired-lessusing pooled eyes dissected from wild-type embryos between E10.5 and E13.5.
1, and Palpha were detected. All P0- or P1-initiated transcripts spliced into exon 4.
a-initiated transcripts included exon 5a, and four had an alternative splice site for
that could be used for initiation of translation. There are no other ATGs located
r heads (hd) dissected from wild-type (WT) or line 3 embryos (Tg) at E10.5. (B)
al., 1997), which is directed towards the C-terminal 17 amino acids of Pax6. This
embryos. (C) The 32/33 kDa protein was not detected using serum 11 (Carriere et
m 11 detected the 46/48 kDa bands, which are full-length Pax6. Because in wild-
8 kDa isoforms, it was necessary to develop the Western to the point where the
soform in the eye extracts prepared from transgenic embryos became obscured.
the developing mouse eye.
Fig. 12. Over-expression of Pax6ΔPD causes a microphthalmic phenotype in
wild-type mice and enhances the Sey phenotype. (A–C, F) Pax6+/+ animals. (D–
E) Pax6+/− animals. (B–C) Whereas wild-type mice (Pax6+/+) carrying 8 (Tg15)
or 10 (Tg3) copies of the BAC transgene have morphologically normal eyes (B),
all animals carrying 16 (Tg15/Tg15) or 18 (Tg3; Tg15) copies exhibit severely
microphthalmic eyes (C). (E) A similar phenotype is observed in Pax6+/− mice
carrying either 8 (Tg15) or 10 (Tg3) copies of the BAC transgene. (F) Section cut
through the eye of a mouse carrying 18 copies of the BAC transgene on a wild-
type background. Nuclei are labeled in blue with Hoechst. Cells expressing Pax6
are labeled in red, and those expressing EGFP are green. The microphthalmic
eye is disorganized and lacks a lens. Although abnormal in appearance, the
retina has a ganglion cell layer, inner nuclear layer, and outer nuclear layer. The
vitreous body is filled with mesenchymal cells. Because the BAC transgene is a
source of Pax6ΔPD, these data demonstrate that Pax6ΔPD acts on eye
development in a dosage-dependent fashion and suggests that this isoform
interacts antagonistically with paired-containing Pax6 isoforms.
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protein extracts were prepared from eyes dissected from wild-
type embryos at E10.5 and then probed with two different Pax6
antisera in Western blots, one directed towards the C-terminal
portion of Pax6 and the other directed towards the paired domain
(Carriere et al., 1993). Consistent with the results from the
RACE experiments, the antisera directed towards the C-terminal
portion of Pax6 detected a 32/33 kDa isoform of Pax6 in eye
extracts but not whole-head extracts (Fig. 11B). This isoform
was not detected using the paired domain antisera (serum 11),
indicating that the 32/33 kDa isoform lacks the paired domain
(Fig. 11C). In contrast, the 46 and 48 kDa Pax6 isoforms, which
are translated from P0- and P1-initiated transcripts, were detected
by both antisera in extracts from both the head and eye. The
amount of 32/33 kDa isoform in eye extracts was small
compared to the 46/48 kDa isoforms (Fig. 11B). To test if the
transgene exhibited similar expression, extracts were prepared
from the eyes and heads of transgenic embryos (line 3
heterozygotes) and probed for Pax6. As for wild-type embryos,
the antisera directed towards the C-terminal portion of Pax6
detected a 32/33 kDa isoform that was greatly enriched in eye
extracts (Fig. 11B), and this isoform was not detected using
serum 11 (Fig. 11C). Because these embryos harbored 10 copies
of the transgene, the amount of the 32/33 kDa isoform expressed
in the eye was greater than for non-transgenic embryos (Fig.
11B). Together, these data demonstrate, for the first time, that a
paired-less isoform of Pax6 is expressed in the developing
mouse eye.
Pax6 immunoreactivity using the C-terminal antisera was
also detected in the rostral telencephalon of Tg;Pax6−/−
embryos (Fig. 10L). Although Pax6 mutant mice and rats
lack an olfactory bulb (Dellovade et al., 1998; Grindley et al.,
1997), they develop an olfactory-bulb-like structure (OBLS) in
the rostrolateral telencephalon (Jimenez et al., 2000). The
OBLS forms as the result of abnormal migration of mitral cell
progenitors (Nomura and Osumi, 2004). In both wild-type and
Pax6 mutant rodents, the mitral cell progenitors originate from
the rostral part of the telencephalon; however, in Pax6−/−
rodents, the mitral cells then mismigrate caudally toward the
lateral part of the telencephalon forming the OBLS (Nomura
and Osumi, 2004). The OBLS can be morphologically
identified in sections cut through the rostral telencephalon of
E13.5 Pax6mutant mice (Figs. 10K, L) (see also, Jimenez et al.,
2000; Lopez-Mascaraque et al., 1998). In these sections, EGFP
is expressed by cells in the rostral telencephalon and strongly
expressed by cells in the OBLS (Fig. 10K). Additionally,
scattered EGFP-expressing cells are observed in the mantle
throughout the rostral telencephalon (arrowheads, Fig. 10K).
Similar to the developing optic vesicle, Pax6 immunoreactivity
using the C-terminal antisera is observed in a subset of the
EGFP-expressing cells (Fig. 10L). At this time, no immunor-
eactivity is observed in the EGFP-expressing cells in the
ventricular region of the rostral telencephalon. However, strong
immunoreactivity is observed in the OBLS and in scattered cells
in the mantle region (Fig. 10L). These Pax6-expressing cells
also express EGFP. These data indicate that cells in the olfactory
bulb express Pax6ΔPD.Over-expression of Pax6ΔPD causes eye defects
To test if Pax6ΔPD had a role in eye development, we
examined the eye phenotype in adult wild-type animals
harboring different copy numbers of the BAC transgene.
Whereas all animals carrying 8 (Tg15) or 10 (Tg3) copies of
the transgene had morphologically normal eyes (Fig. 12B), all
animals carrying 16 (Tg15/Tg15) or 18 (Tg3, Tg15) copies of the
transgene had severely microphthalmic eyes (Fig. 12C).
Histological analysis revealed that these eyes were highly
disorganized and lacked lenses (Fig. 12F). The retina, though
abnormal in appearance throughout much of the eye, had a
ganglion cell layer, inner nuclear layer, and an outer nuclear
layer (Fig. 12F, data not shown). The vitreous body was filled
with mesenchymal cells. Because an identical phenotype was
obtained in animal compound for lines 3 and 15, the eye defects
cannot be explained by homozygosity at the transgene loci.
These results demonstrate that Pax6ΔPD acts on eye develop-
ment in a dosage-dependent fashion.
Previous studies have shown that the human PAX6 locus
rescues the Sey phenotype (Schedl et al., 1996). To test if
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eyes of Pax6+/− mice carrying 8 or 10 copies of the transgene.
Rather than exhibiting a rescue of the Sey phenotype, all of
these animals had severely microphthalmic eyes (Fig. 12E).
Although the eye phenotype in Pax6+/− animals can be variable,
all transgenic Sey animals exhibited comparable microphthal-
mic phenotypes, and these phenotypes were always distinguish-
able from the Sey phenotype. Histological analysis revealed that
the microphthalmic eyes from transgenic Sey mice were
comparable to those obtained from wild-type mice carrying
16–18 copies of the transgene. Together, these results
demonstrate that Pax6ΔPD has a role in eye development and
indicate that this isoform functions differently than the paired-
containing isoform.
Discussion
We report here our analysis of mice transgenic for a 160 kb
mouse Pax6 BAC transgene. Because transcriptional control of
Pax6 is complex, the use of large genomic constructs avoids
potential problems associated with conventional transgenic
reporter gene approaches. Although conventional transgenes are
effective in determining if a given sequence is sufficient for
expression in a particular expression pattern or subdomain of a
more complex expression pattern, this approach fails to take into
account cooperative interactions between elements that would
normally exist within the genome. Consequently, potential
discrepancies can arise between the activities ascribed to a
regulatory element based on its behavior in a classical transgenic
assay and its normal function within the genome. Such
discrepancies have been observed for cis regulatory elements
within the HoxD complex (Beckers and Duboule, 1998) and
were suggested for Pax6, especially with respect to the elements
controlling Pax6 transcription in the eye and diencephalon.
Long-range interacting elements control of Pax6 transcription
in the eye
Normal Pax6 transcription in the eye appears to require the
coordinated actions of multiple cis regulatory elements, which
are widely spaced within the Pax6 locus. Although specific
enhancers for the lens and cornea are located 5′ to P0 and
enhancers for the retina are located 5′ to Palpha, within intron
7, and 3′ to Pax6 in the C1170/Box 123 region (Griffin et al.,
2002; Kammandel et al., 1999; Kleinjan et al., 2004;
Williams et al., 1998; Xu et al., 1999), activation of these
elements requires the activity of elements located within the
DRR. This idea first came from aniridia cases in which
chromosomal rearrangements disrupted the region 3′ to PAX6
but spared the PAX6 transcription unit (Fantes et al., 1995;
Fukushima et al., 1993; Kleinjan et al., 2001; Lauderdale et
al., 2000; Simola et al., 1983; Ton et al., 1991). Because the
clinical manifestations of these patients are indistinguishable
from aniridia patients with PAX6 coding deletions or
truncations, it was suggested that cis regulatory elements
located 3′ to PAX6 are required for normal expression
(Lauderdale et al., 2000).To better define distal 3′ Pax6 enhancer elements, Pax6
BAC-transgenic mice were generated. Because the BAC
293d08 transgene faithfully replicated Pax6 expression in the
eye, it is likely that this BAC contains all of the regulatory
elements required for normal Pax6 eye expression. When
compared to the results from mice harboring YACs Y589 and
Y593 (Kleinjan et al., 2001; Schedl et al., 1996), this indicates
that regulatory elements located between SIMO and Elp4 exon
7 are necessary for normal Pax6 transcription in the eye and
implies that these elements interact with those elsewhere within
the Pax6 transcript unit, including those 5′ to P0, Palpha, within
intron 7, and in C1170/Box 123. Thus, Pax6 transcription in the
eye appears to require the coordinated interactions of widely
spaced regulatory elements, perhaps through combinatorial
binding to the same regulatory proteins or complexes, as might
be expected to occur via a looping model of long-range gene
control (Bulger and Groudine, 1999; de Laat and Grosveld,
2003; Engel and Tanimoto, 2000; Tolhuis et al., 2002).
Interacting elements control Pax6 transcription in the
diencephalon
In contrast with the eye, our BAC transgene only partially
recapitulates Pax6 expression in the diencephalon. Whereas
Pax6 is normally expressed in the dorsal diencephalon,
ventral thalamus, and at the pt/mes boundary, transgene
expression was observed in the ventral thalamus and in a
cluster of cells at the pt/mes boundary. This result was
unexpected because this BAC contains all previously
described diencephalic regulatory elements (Griffin et al.,
2002; Kleinjan et al., 2001, 2004). In fact, this BAC contains
diencephalic enhancers located between P0 and P1, (Kam-
mandel et al., 1999; Xu et al., 1999), within intron 7 (Griffin
et al., 2002; Kleinjan et al., 2004), C1170/Box 123 (Griffin et
al., 2002; Kleinjan et al., 2004), and in the DRR (Kleinjan et
al., 2001, 2004). This result suggests that the diencephalic
enhancers controlling expression in the dorsal diencephalon
are interacting with an as yet unidentified regulatory element
that is missing from BAC 293d08.
Although it is possible that this missing diencephalic element
is located 5′ to Pax6, we propose that it is located remotely 3′ to
Pax6 and functionally divides the DRR into two regions. This
proposal stems from comparison of the results of our BAC study
to those reported for mice harboring the human PAX6 YACs
(Kleinjan et al., 2001; Schedl et al., 1996). Whereas the YAC
Y593 transgene was expressed in a Pax6 expression pattern in
the diencephalon of transgenic mice, the Y589 transgenewas not
(Kleinjan et al., 2001). Because these two YACs are comparable
5′ to Pax6 but differ significantly at their 3′ ends, this difference
in expression suggests that a diencephalic regulatory element,
missing from both BAC 293d08 and YAC Y589, is located
within the DRR. Comparison of the location of the 3′ ends of
YAC Y593 and BAC 293d08 (Fig. 1B) suggests that this
element is located between Elp4 exon 4 and 7. Thus, it is likely
that the DRR can be functionally divided into an eye regulatory
region (between SIMO and Elp4 exon 7) and a diencephalic
regulatory region (between Elp4 exon 7 and 4). We are currently
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diencephalon could have expressed transcripts that initiated
only from the Palpha or P4 promoters, which would not be
reported by our BAC transgene. Although Palpha-initiated
transcripts were identified, cells transcribing Pax6 from this
promoter also utilized the P0 and P1 promoters. Thus, Pax6
transcription in diencephalon, like the eye, appears to require the
coordinated interactions of multiple cis regulatory elements
widely distributed across the Pax6 locus.
Paired-less Pax6 in the developing eye and olfactory bulb
We provide evidence that a paired-less Pax6 isoform is
expressed in the developing eye and olfactory bulb in mammals.
Pax6 transcripts that initiate from P0 and P1 typically encode a
Pax6 protein that contains a paired domain, paired-type
homeodomain, and a PST-rich C-terminal region. However, a
paired-less isoform of Pax6 has been identified in both birds
(Carriere et al., 1993) and nematodes (Chisholm and Horvitz,
1995; Zhang and Emmons, 1995). The possibility that a
truncated Pax6 isoform was also expressed in mammals was
raised by the identification of the Palpha (Kammandel et al.,
1999) and P4 (Kleinjan et al., 2004) Pax6 promoters. Because
this isoform is expected to be identical to the full-length Pax6
protein in all respects except the paired domain, it is not possible
to distinguish between paired-less and paired-containing Pax6
proteins in wild-type embryos using immunohistochemistry.
However, by taking advantage of the attributes of our BAC
transgene and the SeyNeu allele, we were able to show that
Pax6ΔPD is expressed in the optic vesicle and rostral
telencephalon in Pax6 mutant embryos (Figs. 10F, L). Although
both the eye and olfactory bulb develop abnormally in Pax6
mutant mice, these structures share some similarities with wild-
type embryos (Baumer et al., 2003; Jimenez et al., 2000).
Therefore, the presence in Tg;Pax6−/− embryos of Pax6
immunoreactivity in the retinal portion of the optic vesicle
and also in the OBLS suggests that a truncated form of Pax6 is
expressed in the developing eye and olfactory bulb of wild-type
embryos. Consistent with this, we showed by Western blot that
a paired-less isoform of Pax6 is present in protein extracts
prepared from the developing eyes of wild-type embryos.
Although transcripts initiating from either Palpha or P4 are
predicted to encode for a Pax6ΔPD protein, transcript analysis
indicates that the Palpha promoter is likely to be the primary
source of this isoform in the developing eye (Fig. 11A). Both
the transcript analysis and Western blot indicate that Pax6ΔPD
is expressed at lower levels than full-length Pax6. Although this
low-level expression may indicate that the truncated protein is
functionally unimportant and its expression an evolutionary
vestige, alternatively, the paired-less isoform may have an
important functional role, which necessitates tight control over
its expression. This latter possibility raises some interesting
questions about Pax6 function during oculogenesis and
olfactory development.
Pax6 is involved in multiple aspects of eye development
and affects cell proliferation, cell fate, and morphogenesis.
Recent studies addressing the function of the paired domainand homeodomain have demonstrated that both the PD and
HD are important for the regulation of proliferation and cell
fate in the eye and indicate that different aspects of Pax6
gene function are mediated by the different isoforms of the
Pax6 protein (Azuma et al., 2005; Dominguez et al., 2004;
Favor et al., 2001; Haubst et al., 2004). Whereas Pax6 is
necessary (Glaser et al., 1994; Hill et al., 1991; Hogan et
al., 1986) and sufficient (Chow et al., 1999; Onuma et al.,
2002) for eye development in vertebrates, Pax6(5a) appears
to have a more restricted role. Mutations affecting the Pax6
(5a) protein are found in patients with foveal hypoplasia
(Azuma et al., 1996, 1999), and mice that lack exon 5a
exhibit iris hypoplasia (Singh et al., 2002). In patients, a
splice acceptor mutation that increases the relative abun-
dance of the Pax6(5a) isoform causes distinct abnormalities
in the iris (Epstein et al., 1994). However, Pax6 and Pax6
(5a) both promote proliferation in the retina (Azuma et al.,
2005; Marquardt et al., 2001). Thus, Pax6(5a) appears to act
in a spatially restricted manner to control the development
of specific structures within the eye. Could the same be true
of Pax6ΔPD?
We show that Pax6ΔPD also has a role in eye development.
Over-expression of Pax6ΔPD in cells that normally express this
isoform results in severe microphthalmia in both Pax6+/+ and
Pax6+/− animals. Although the cellular defects underlying this
phenotype remain to be determined, histological analysis
revealed an abnormally shaped retina within the eye, mesench-
ymal cells in the vitreous body, and agenesis of the lens. The
retina itself was layered and contained RGCs and photorecep-
tors. The lack of a lens was striking and suggests that Pax6ΔPD
has a role in lens development. Consistent with this idea, the HD
of Pax6 appears to mediate the early role of Pax6 in the surface
ectoderm for lens formation. Mice homozygous for a missense
mutation in the homeodomain develop a rudimentary retinal
neuroepithelium and the surface ectoderm begins to invaginate,
however, no lens develops (Favor et al., 2001). Comparison of
the eye phenotypes that result from over-expression of
Pax6ΔPD with those from over-expression of Pax6 suggests
that these two isoforms function differently. Although mice
carrying 5–10 copies of the human PAX6 locus on a wild-type
background also exhibit a microphthalmic phenotype, their eyes
had a distinct retina, iris, cornea, and lens (Schedl et al., 1996).
More dramatically, the human PAX6 locus rescues the Small eye
mutant phenotype (Schedl et al., 1996). Taken together, these
results indicate that Pax6ΔPD interacts antagonistically with
Pax6 during eye development. Consistent with this interpreta-
tion, genetic analysis of the Pax6 locus in C. elegans indicates
that Pax6 isoforms can interact additively, synergistically, or
antagonistically, depending on the cellular context (Cinar and
Chisholm, 2004). Together, these results suggest that Pax6ΔPD
is likely to act as a dominant-negative isoform in eye
development.
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